SC: Omitted Relief Barred Despite Liberty to File Fresh Suit under Order 23 || SC: Custodial Confession Alone Cannot Justify Preventive Detention || SC: Failure to Pay Balance Sale Amount Can Lead to EMD Forfeiture under Auction Terms || Gujarat HC: CIC Cannot Order Suo Motu Disclosure of PM Modi’s Degree under RTI Act || MP HC: FIR Cannot Be Quashed Merely for Not Specifying Accused’s Role || MP HC: Joint Family Status Alone Does Not Establish Existence of Joint Family Funds || MP High Court Directs State Bar Council to Frame Stipend Guidelines for Junior Advocates || Allahabad High Court: Hookah Bars cannot Operate in UP; Clean Air Prevails over Trade || P&H HC: High Court’s Inherent Powers Cannot Be Used to Entertain a Second Revision || Delhi HC: Magistrate Must Examine Complainant, Hear Accused Before Taking Cognisance

Delhi HC Issues Notice in PIL Seeking Selling of Remdesivir by All Pharma Firms in Domestic Market - (04 May 2021)

CIVIL

Delhi High Court has issued notice to the Centre and various pharma majors asking them to respond to a Public Interest Litigation seeking that all drug firms involved in the making Remdesivir be allowed to sell it in the domestic market. The Court has issued the notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade, and various pharma companies, like Cipla, Zydus, and Cadila, seeking their stand on the issue.

Tags : DELHI HIGH COURT SELLING OF REMDESIVIR

Share :